Process development of clinical anti-HBV drug Y101: identification and synthesis of novel impurities
Crossref DOI link: https://doi.org/10.1007/s11164-015-2169-0
Published Online: 2015-07-15
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Zhanxing
Liao, HaiJian
An, Qiao
Pan, Weidong
Cao, Peixue
Liu, Changxiao
Huang, Zhengming
Xia, Wen
Xu, Bixue
Liang, Guangyi
Text and Data Mining valid from 2015-07-15